Edelweiss Mutual FundPharmaVery High Risk

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth

Current NAV₹11.61as of 30/5/2026

AUM4716.00 Cr

AUM

4716.00 Cr

Expense Ratio

1.95%

Min SIP

₹500

Min Lumpsum

₹1000

Launch Date

3 April 2006

Exit Load

Nil

Riskometer

LowModerateHighVery High

Risk Level: Very High

Volatility: 14.42 | Sharpe Ratio: -2.66

Fund Manager & Key Metrics

Fund ManagerBharat Lahoti(3.5 years yrs)

Volatility14.42

Sharpe Ratio-2.66

Portfolio Turnover38%

BenchmarkNifty Pharma TRI

Holdings Date25/5/2026

Asset Allocation

Equity: 96.00% | T-Bills: 4.00%

Investment Objective

Aims to provide capital appreciation by investing in Pharma securities

Top Holdings

As of 25-May-2026

1. Sun Pharmaceutical Industries Ltd.20.5%

2. Dr. Reddy's Laboratories Ltd.12.8%

3. Cipla Ltd.10.4%

4. Divi's Laboratories Ltd.9.8%

5. Torrent Pharmaceuticals Ltd.7.2%

6. Aurobindo Pharma Ltd.5.8%

7. Alkem Laboratories Ltd.5.2%

8. Lupin Ltd.4.9%

9. Ipca Laboratories Ltd.3.8%

10. Mankind Pharma Ltd.3.5%

Overview

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth investment objective and strategy

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth ka investment objective hai ki ye pharma sector mein growth potential ko capitalize kare. Ye fund un investors ke liye suitable hai jo high growth opportunities ki talash mein hain aur long-term wealth creation ki soch rakhte hain. Is fund ka investment strategy hai ki wo equity allocation ke zariye pharma companies mein invest kare, jo ki innovative aur growth-driven hain. Agar aapko market volatility se dar nahi hai aur aap long-term growth chahte hain, toh ye fund aapke liye ek acha option ho sakta hai.

Performance & Analysis

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth ke returns – 1, 3, 5 saal ke aankde

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth ke 1 saal, 3 saal, aur 5 saal ke returns abhi tak kuch khaas nahi rahe hain. Is fund ne 1Y, 3Y, aur 5Y returns mein 0% dekha hai. Aisa lagta hai ki ye fund benchmark Nifty Pharma TRI ke sath consistency nahi bana paya hai. Jab hum iske risk ko dekhe, toh fund manager Bharat Lahoti ki 3.5 saal ki tenure ke baad, kuch investors ko iski performance pe khud se sawal karne padte hain. Volatility bhi kaafi high hai, aur is wajah se investors ko caution zaroor rakhna chahiye. Is fund ka performance ek alag point of view se dekha ja sakta hai, kyunki pharma sector ka growth depend karta hai market dynamics aur demand supply ke factors par. Investors ko ye samajhna hoga ki kabhi kabhi market conditions aise bhi hote hain, jahan returns expected se alag ho sakte hain.

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth top holdings and portfolio allocation

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth ki top holdings mein Sun Pharmaceutical Industries Ltd. (20.5%), Dr. Reddy's Laboratories Ltd. (12.8%), Cipla Ltd. (10.4%), Divi's Laboratories Ltd. (9.8%), aur Torrent Pharmaceuticals Ltd. (7.2%) shamil hain. Ye holdings fund ki strategy se align karti hain, kyunki ye sabhi companies industry ke top players hain aur unka growth potential bhi achha hai. Fund ki overall portfolio allocation bhi pharma sector pe focused hai, jo ki investors ko sector-specific exposure deta hai. Isne high growth mutual funds ki category mein ek unique position bana rakhi hai. Agar aap ek diversified portfolio chahte hain, toh ye fund aapko ek strong position provide kar sakta hai, lekin aapko market volatility ki risks se bhi aware rehna hoga.

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth riskometer and downside risk

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth ka riskometer "Very High" hai. Iska matlab hai ki is fund mein invest karna high risk ke sath judta hai. Agar aap risk-averse investor hai, toh ye fund aapke liye suitable nahi ho sakta. Market volatility is fund ki returns ko impact kar sakti hai. Sharpe Ratio ki data available nahi hai, lekin ye zaroor samajhna zaroori hai ki is fund ka downside risk kaafi zyada hai. Isliye, agar aap long-term investing ki soch rakhte hain aur aapko market risks se dar nahi hai, tabhi is fund ke liye sochiye.

Who Should Invest?

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth – aage kya? (long term outlook)

Agar hum long-term outlook ki baat karein, toh Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth mein future growth potential hai. Pharma sector historically strong raha hai, aur aane wale time mein bhi iski growth expectations achhi hain. Investors jo long-term SIP exposure ki talash mein hain, unke liye ye fund suitable ho sakta hai. Market mein kuch trends hain jo is sector ko support kar sakte hain, jaise ki healthcare ki demand mein badhotri aur innovative treatments ka development. Lekin yeh bhi samajna hai ki returns ka prediction karna mushkil hai. Updated in May 2026, is fund ka performance aapke investment horizon ko dekhte hue vary kar sakta hai.

Pros & Cons

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth – fayde aur nuksan

High growth potential in pharma sector
Diversified exposure to top pharma companies
Managed by experienced fund manager
Suitable for aggressive investors looking for long-term gains

Very high risk profile
Zero returns in the last 1, 3, and 5 years
High expense ratio of 1.95%

Frequently Asked Questions

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth – aksar puche jaane wale sawaal (FAQs)

Kya Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth SIP ke liye suitable hai?

Haan, ye fund SIP ke liye suitable ho sakta hai agar aap long-term growth chahte hain, lekin risk ko dhyan mein rakhna hoga.

Edelweiss Mutual Fund Pharma Fund - Regular Plan - Growth mein invest karne se tax implications kya hain?

Investors ko capital gains tax face karna pad sakta hai, jo ki aapke holding period par depend karta hai.

Is fund ka risk level kya hai?

Is fund ka riskometer "Very High" hai, jo ki high volatility aur market risks ko dikhata hai.

Returns

Period	Fund Return (%)	Benchmark (Nifty Pharma TRI) (%)
1 Year	0%	—
3 Years	0%	—
5 Years	0%	—
Since Launch	0.48%	—

SIP Calculator

SIP / Lumpsum Calculator

Monthly SIP Amount (₹)

SIP Period (Years)

Hold Period After SIP (Years)

Annual Step-Up (%)

Return Scenario

Based on fund's 1Y return of 12.0%

Invested: ₹956k

Gains: ₹15642k

Total Invested

₹956245.48

Total Returns

+ ₹15641892.92

Maturity Value

₹16598138.40

SIP of ₹5000 for 10 years (stepping up 10% annually), then held for 20 years at 12.0% p.a.

*Projected returns are for illustration only. Past performance does not guarantee future returns.

Similar Funds

Related Funds in Pharma

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth Groww Mutual Fund Pharma Fund - Regular Plan - Growth Quantum Mutual Fund Pharma Fund - Regular Plan - Growth Sundaram Mutual Fund Pharma Fund - Regular Plan - Growth Bandhan Mutual Fund Pharma Fund - Regular Plan - Growth

Compare with Alternatives

Disclaimer: Mutual fund investments are subject to market risks. Please read all scheme‑related documents carefully before investing. Past performance does not guarantee future returns. The content on this page is for educational purposes only.